Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Quinoline LTD4/LTE4 inhibitors from Ciba-Geigy

Sep. 27, 1996

E. Merck reports PDE IV inhibitors

Sep. 27, 1996

New cough/cold remedy introduced in the U.S.

Sep. 27, 1996

New hay fever remedy available for the fall allergy season

Sep. 27, 1996

Sepracor updates progress on (R)-albuterol

Sep. 20, 1996

Customized asthma treatment introduced in the U.S.

Sep. 20, 1996

LTD4 antagonist selected for further evaluation by Menarini

Sep. 20, 1996

Schering AG investigates LTB4 inhibitors

Sep. 20, 1996

5-LO inhibitor from Bristol-Myers Squibb

Sep. 20, 1996

Anti-IL-8 antibodies claimed by Genentech

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...